(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QUIDEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

QUIDEL

ST13

US500000086445815

Class

1, 5, 9, 10, 42

Filing

86445815

Registration

5110309

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

64

Latest update

12/28/2025

Trademark type

Word

Nice classes

1, 5, 9, 10, 42

Filing date

11/05/2014

Registration date

12/27/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/13/2023

Last transaction

12/28/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/30/1984

First use in commerce

01/30/1984

Drawing code

4

Owner type

03

Owner location

RARITAN, NJ

Examiner

MONINGHOFF,KIM TERESA

Law office

M40

Current location

TMO LAW OFFICE 113

Holders and representatives

Holders

ORTHO-CLINICAL DIAGNOSTICS, INC.
Q. C. (pessoa física)

Representatives

Alexis Crawford Douglas K&L Gates LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic reagent test kits comprised of monoclonal antibodiesbuffersreagents for clinical or medical laboratoryscientific or research use; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor clinical laboratory use

Class 5

In vitro medical diagnostic test kits for clinicalprofessionalmedical or consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease; chemicalbiochemical and biological preparations for medical use in cassette formfor use in measuringtesting and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposesfor use in connection with diagnostic test kits for the detection of a wide variety of diseasesconditionsdisorders; diagnostic reagent test kits comprising detection and identification staining reagentsassociated quality control reagentscustomized microscopy slidesfor medical and clinical use

Class 9

Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens; clinical laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; automated fluorescent-based microscopy system comprising light-emitting diodes (LED)objective lensdigital camera charge-coupled device (CCD)motorized slide carrierdiagnostic software for data reduction; wireless routers; gateway routers in the nature of computer control hardware; computer software for capturingorganizingreportingmanagement of medical information and data

Class 10

Devices in the nature of glass slidescupsbags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of glass slidescupsbags and test components in the nature of medical testing devices sold as a kit for the collectionpreservation and shipment of bodily excretions and fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of an optics windowa port for a reagent testan illuminating devicespecifically adapted for reading in vitro medical test results; medical diagnostic analyzers for measuringtesting and analyzing blood and other bodily fluids

Class 42

Providing a website portal featuring technology that allows users to access medical information and data; providing temporary use of on-line non-downloadable cloud computing software for capturingorganizingreportingremote management of medical information and data

Publications

History of USPTO decisions and trademark events.

64 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/27/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/10/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/14/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/26/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/13/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/13/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/13/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/03/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/03/2023

E815

TEAS SECTION 8 & 15 RECEIVED

12/12/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/22/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/27/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/04/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/04/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/04/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/16/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/16/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/16/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/16/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/16/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

12/27/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/23/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/22/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/22/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/22/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/15/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/17/2016

GNRT

NON-FINAL ACTION E-MAILED

10/17/2016

CNRT

SU - NON-FINAL ACTION - WRITTEN

10/17/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/15/2016

IUAF

USE AMENDMENT FILED

10/05/2016

EISU

TEAS STATEMENT OF USE RECEIVED

10/05/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/25/2016

EX2G

SOU EXTENSION 2 GRANTED

06/24/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/22/2016

EXT2

SOU EXTENSION 2 FILED

05/23/2016

EEXT

SOU TEAS EXTENSION RECEIVED

05/23/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/22/2015

EX1G

SOU EXTENSION 1 GRANTED

12/18/2015

EXT1

SOU EXTENSION 1 FILED

12/18/2015

EEXT

SOU TEAS EXTENSION RECEIVED

12/18/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/02/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/02/2015

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/30/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/05/2015

PUBO

PUBLISHED FOR OPPOSITION

05/05/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/15/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/27/2015

ALIE

ASSIGNED TO LIE

03/23/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/03/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

03/03/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/03/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

03/03/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/03/2015

DOCK

ASSIGNED TO EXAMINER

02/25/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/14/2014

NWAP

NEW APPLICATION ENTERED

11/08/2014

Continuous trademark protection

Get notified about every new filing that threatens QUIDEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.